White Paper

Preparing Clinical Trial Documents For Europe's New CTIS

document file iStock-1212785891.jpg

European Clinical Trial Regulation (EU-CTR) 536/2014 is expected to go into application in January 2022 with the go-live of the Clinical Trial Information System (CTIS). It will require all stakeholders to submit clinical trial information through the CTIS electronic platform.

With the regulation pending, the need to create regulatory documents with disclosure in mind has never been more important. Sponsors should design and use document templates to streamline the process. Templates help ensure that the content is disclosure ready, with selected elements of the protocol & clinical study report (CSR) written in plain language, which ensures consistency and ensure consistency across studies, disease states, regulatory agencies, and documents such as the informed consent form (ICF) and plain language summaries (PLS).

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Informa Pharma Intelligence